Generic diabetes combo drug put to the test in healthy volunteers
NCT ID NCT07633015
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study checked whether a generic version of the diabetes drug empagliflozin/metformin is absorbed into the body the same way as the brand-name drug Synjardy. 42 healthy adults took a single dose of each tablet under fed conditions. The goal was to see if the two versions are bioequivalent, meaning they work equally well.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Empagliflozin and Metformin combination tablet
What this could lead to
If successful, this could confirm that the generic version is equivalent to the brand-name drug, potentially offering a lower-cost option for patients.
What could go wrong
This is a small, early-stage bioequivalence study in healthy volunteers, not patients. Results may not predict real-world effectiveness or safety in people with diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Axis Clinicals Latina, S.A. de C.V.
Mexico City, Mexico City, 07870, Mexico